Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects

Health Canada started a safety review following a review done by the FDA on systemic (taken by mouth or by injection) fluoroquinolone drugs. The FDA review showed that there were persistent (lasting 30 days or longer after stopping use of fluoroquinolones) and disabling side effects linked to the use of fluoroquinolone products.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2017-11-02 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["Examen sommaire de l'innocuité", "Fluoroquinolones", "évaluation", "risque", "effets secondaires persistants et invalidants"], "en": ["Summary Safety Review", "Fluoroquinolones", "assessing", "risk", "persistent-and-disabling side effects"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source